What does Harbin Medisan Pharmaceutical Co., Ltd. do?

Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 002900.SZ's market cap?

Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) has a market capitalization of approximately $4.31 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 002900.SZ pay a dividend?

Yes — Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) pays a dividend annually, with a trailing-twelve-month yield of 1.47%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 002900.SZ profitable?

Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

002900.SZ

Harbin Medisan Pharmaceutical Co., Ltd.

SHZ·Drug Manufacturers, Specialty & Generic · Healthcare

¥13.62¥0.47−3.34%

Market cap¥4.31B·Market closed·Aug 26 7:04 AM UTC

Price Chart

¥13.62−¥0.47 (−3.34%)today

−39.14%CAGR −9.46%

Select date range

FromTo

Sep 22, 2017Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)−6.5%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.200

Ex-Dividend DateMay 29

Payment DateMay 29

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 16

Last Report DateApr 27

Reported vs Estimate−¥0.41

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥813.23M

Net Income−¥317.84M

Net Margin−39.1%

Operating Cash Flow−¥105.33M

Capital Expenditures¥202.49M

Free Cash Flow−¥307.82M

Return on Equity−18.0%

Return on Invested Capital−0.6%

Net Debt¥578.35M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 002900.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 002900.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 002900.SZ and 80,000+ other tickers.

About Harbin Medisan Pharmaceutical Co., Ltd.

Established in 1996 and based in Harbin, China, Harbin Medisan Pharmaceutical Co., Ltd. specializes in the full lifecycle of chemical pharmaceutical products within China, from research and development to manufacturing and sales. The company's comprehensive product line includes both active pharmaceutical ingredients (APIs) and various finished drug forms. Its offerings address a wide array of medical conditions, encompassing treatments for neurological, cardiovascular, and musculoskeletal systems, systemic infections, nutritional support, fluid balance, and other general healthcare needs.

CEO: Jian Fei Qin
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHZ
Employees: 2,086
Website: www.medisan.com.cn

Peers

Peers Tab

300683.SZ

Wuhan Hiteck Biological Pharma Co.,Ltd

Cap

¥3.4B

300086.SZ

Honz Pharmaceutical Co., Ltd.

Cap

¥3.1B

600479.SS

ZhuZhou QianJin Pharmaceutical Co.,Ltd

Cap

¥5.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 002900.SZ

What does Harbin Medisan Pharmaceutical Co., Ltd. do?: Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 002900.SZ's market cap?: Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) has a market capitalization of approximately $4.31 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 002900.SZ pay a dividend?: Yes — Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) pays a dividend annually, with a trailing-twelve-month yield of 1.47%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 002900.SZ profitable?: Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.